Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause Interstitial lung disease? 57 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Interstitial lung disease have been filed in association with DOCETAXEL\DOCETAXEL ANHYDROUS. This represents 1.5% of all adverse event reports for DOCETAXEL\DOCETAXEL ANHYDROUS.
57
Reports of Interstitial lung disease with DOCETAXEL\DOCETAXEL ANHYDROUS
1.5%
of all DOCETAXEL\DOCETAXEL ANHYDROUS reports
17
Deaths
32
Hospitalizations
How Dangerous Is Interstitial lung disease From DOCETAXEL\DOCETAXEL ANHYDROUS?
Of the 57 reports, 17 (29.8%) resulted in death, 32 (56.1%) required hospitalization, and 13 (22.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOCETAXEL\DOCETAXEL ANHYDROUS. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause?
Diarrhoea (409)
Myelosuppression (404)
Disease progression (289)
Off label use (281)
Nausea (279)
Neutropenia (250)
Fatigue (236)
Pyrexia (221)
Vomiting (216)
Asthenia (190)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DOCETAXEL\DOCETAXEL ANHYDROUS Alternatives Have Lower Interstitial lung disease Risk?
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCOSANOL
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCUSATE